I want to donate
Main lines of research

Improve the detection and management of patients with intermediate cardiovascular risk and the detection of CV disease in the asymptomatic phase and analyse the cost effectiveness of interventions for the prevention of cardiovascular disease.

Strategic objectives
    • Analyse the role of emerging risk factors and asymptomatic atherosclerosis, as well as the comorbidity of the patient in predicting cardiovascular risk.
    • Develop cardiovascular risk functions adapted to specific subpopulation groups (diabetes, patients with family history of vascular disease, obesity).
    • Evaluate the effectiveness and efficiency of different interventions for prevention and control of arteriosclerotic disease in primary care using SIDIAP.
    • Analyse the role of CV risk factors and their monitoring in the incidence of dementia.

Escrichs A, Biarnes C, Garre-Olmo J, Fernández-Real JM, Ramos R, Pamplona R, Brugada R, Serena J, Ramió-Torrentà L, Coll-De-Tuero G, Gallart L, Barretina J, Vilanova JC, Mayneris-Perxachs J, Essig M, Figley CR, Pedraza S, Puig J, Deco G

Whole-Brain Dynamics in Aging: Disruptions in Functional Connectivity and the Role of the Rich Club.

CEREBRAL CORTEX, 2021, 31, 2466-2481

Garre-Olmo J, Turró-Garriga O, Martí-Lluch R, Zacarías-Pons L, Alves-Cabratosa L, Serrano-Sarbosa D, Vilalta-Franch J, Ramos R, Girona Healthy Region Study Group

Changes in lifestyle resulting from confinement due to COVID-19 and depressive symptomatology: A cross-sectional a population-based study.

COMPREHENSIVE PSYCHIATRY, 2021, 104, 152214-152214

Arnoriaga-Rodríguez M, Mayneris-Perxachs J, Contreras-Rodríguez O, Burokas A, Ortega-Sanchez JA, Blasco G, Coll C, Biarnés C, Castells-Nobau A, Puig J, Garre-Olmo J, Ramos R, Pedraza S, Brugada R, Vilanova JC, Serena J, Barretina J, Gich J, Pérez-Brocal V, Moya A, Fernández-Real X, Ramio-Torrentà L, Pamplona R, Sol J, Jové M, Ricart W, Portero-Otin M, Maldonado R, Fernández-Real JM

Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways.

Gut, 2021, 70, 2283-2296

Puig J, Biarnes C, Pedraza S, Vilanova JC, Pamplona R, Fernández-Real JM, Brugada R, Ramos R, Coll-De-Tuero G, Calvo-Perxas L, Serena J, Ramió-Torrentà L, Gich J, Gallart L, Portero-Otin M, Alberich-Bayarri A, Jimenez-Pastor A, Camacho-Ramos E, Mayneris-Perxachs J, Pineda V, Font R, Prats-Puig A, Gacto ML, Deco G, Escrichs A, Clotet B, Paredes R, Negredo E, Triaire B, Rodríguez M, Heredia-Escámez A, Coronado R, de Graaf W, Prevost V, Mitulescu A, Daunis-I-Estadella P, Thió-Henestrosa S, Miralles F, Ribas-Ripoll V, Puig-Domingo M, Essig M, Figley CR, Figley TD, Albensi B, Ashraf A, Reiber JHC, Schifitto G, Md Nasir U, Leiva-Salinas C, Wintermark M, Nael K, Vilalta-Franch J, Barretina J, Garre-Olmo J

The Aging Imageomics Study: rationale, design and baseline characteristics of the study population.


Janssen O, Vos SJB, García-Negredo G, Tochel C, Gustavsson A, Smith M, Ly A, Nelson M, Baldwin H, Sudlow C, Bexelius C, Jindra C, Vaci N, Bauermeister S, Gallacher J, Ponjoan A, Dufouil C, Garre Olmo J, Pedersen L, Skoog I, Hottgenroth A, Visser PJ, van der Lei J, Diaz C

Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube.

ALZHEIMERS & DEMENTIA, 2020, 16, 461-471

Ponjoan A, Garre-Olmo J, Blanch J, Fages E, Alves-Cabratosa L, Martí-Lluch R, Comas-Cufí M, Parramon D, Garcia-Gil M, Ramos R

Is it time to use real-world data from primary care in Alzheimer's disease?


Garre-Olmo J, Ponjoan A, Inoriza JM, Blanch J, Sánchez-Pérez I, Cubí R, de Eugenio R, Turró-Garriga O, Vilalta-Franch J

Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study.

Clinical Epidemiology, 2019, 11, 525-542

Tochel C, Smith M, Baldwin H, Gustavsson A, Ly A, Bexelius C, Nelson M, Bintener C, Fantoni E, Garre-Olmo J, Janssen O, Jindra C, Jørgensen IF, McKeown A, Öztürk B, Ponjoan A, Potashman MH, Reed C, Roncancio-Diaz E, Vos S, Sudlow C, ROADMAP consortium

What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review.

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 2019, 11, 231-247

Ponjoan A, Garre-Olmo J, Blanch J, Fages E, Alves-Cabratosa L, Martí-Lluch R, Comas-Cufí M, Parramon D, García-Gil M, Ramos R

How well can electronic health records from primary care identify Alzheimer's disease cases?

Clinical Epidemiology, 2019, 11, 509-518

Ponjoan A, Garre-Olmo J, Blanch J, Fages E, Alves-Cabratosa L, Martí-Lluch R, Comas-Cufí M, Parramon D, Garcia-Gil M, Ramos R

Epidemiology of dementia: prevalence and incidence estimates using validated electronic health records from primary care.

Clinical Epidemiology, 2019, 11, 217-228
Competitive projects
Guies clíniques

- Baena Díez, JM; Barcelo Colomer, E; Ciurana Misol, R; Franzi Sisó, A; García Cerdán, MR; Ríos Rodríguez, MA; Ramos Blanes, R; Solanas Saura, P; Vilaseca Canals,J. Colesterol i risc coronari.Barcelona: Institut Català de la Salut, 2009. Guies de pràctica clínica i material docent, núm. 2017

Job offers


If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in